Prawo i regulacje · 12/07/2017

DEA Proposes to Remove Naldemedine from Controlled Substances Schedule

The Drug Enforcement Administration (DEA) is proposing to remove naldemedine, a medication derived from opium alkaloids, from the schedules of the Controlled Substances Act (CSA), effectively lifting regulatory controls and sanctions on its handling and use.